J Nucl Med. 2010 Oct;51(10):1549-58.
doi: 10.2967/jnumed.109.073908.
Epub 2010 Sep 16.
Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potentialapplications.
Kwee TC, Takahara T, Ochiai R, Koh DM, Ohno Y, Nakanishi K, Niwa T, Chenevert TL, Luijten PR, Alavi A.
Radiol Med. 2012 Mar;117(2):293-311.
doi: 10.1007/s11547-011-0708-3.
Epub 2011 Jul 9.
Whole-body MR-DWIBS vs.
[18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.
Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, Niccoli-Asabella A, Palmiotti G, Lasciarrea M, Maggialetti A.
Radiol Med. 2009 Feb;114(1):1-17.
doi: 10.1007/s11547-008-0348-4.
Epub 2008 Dec 11.
Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparisonwith positron emission tomography computed tomography (PET-CT) in a pilot study.
[Article in English,
Italian]
Stecco A, Romano G, Negru M, Volpe D, Saponaro A, Costantino S, Sacchetti G, Inglese E, Alabiso O, Carriero A.
AJR Am J Roentgenol. 2011 Sep;197(3):W384-91.
doi: 10.2214/AJR.10.5692.
Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL.
Eur Radiol. 2010 Aug;20(8):2027-38.
doi: 10.1007/s00330-010-1758-y.
Epub 2010 Mar 23.
Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping forstaging patients with diffuse large B-cell lymphoma.
Lin C, Luciani A, Itti E, El-Gnaoui T, Vignaud A, Beaussart P, Lin SJ, Belhadj K, Brugières P, Evangelista E, Haioun C, Meignan M, Rahmouni A.